Oral Oncology
Volume 39, Issue 7 , Pages 638-647 , October 2003

Quantitative analysis of cathepsin L mRNA and protein expression during oral cancer progression

  • Maricris Macabeo-Ong

      Affiliations

    • Department of Stomatology, UCSF, San Francisco, CA, USA
    • MMO and CHS contributed equally to this paper.
    • ,
  • Caroline H. Shiboski

      Affiliations

    • Department of Stomatology, UCSF, San Francisco, CA, USA
    • UCSF Cancer Center, San Francisco, CA, USA
    • MMO and CHS contributed equally to this paper.
    • ,
  • Sol Silverman

      Affiliations

    • Department of Stomatology, UCSF, San Francisco, CA, USA
    • UCSF Cancer Center, San Francisco, CA, USA
    • ,
  • David G. Ginzinger

      Affiliations

    • UCSF Cancer Center, San Francisco, CA, USA
    • ,
  • Nusi Dekker

      Affiliations

    • Department of Stomatology, UCSF, San Francisco, CA, USA
    • ,
  • David T.W. Wong

      Affiliations

    • Dental Research Institute, UCLA, Los Angeles, CA, USA
    • ,
  • Richard C.K. Jordan

      Affiliations

    • Department of Stomatology, UCSF, San Francisco, CA, USA
    • UCSF Cancer Center, San Francisco, CA, USA
    • Department of Pathology, UCSF, San Francisco, CA, USA
    • Corresponding Author InformationCorresponding author. Present address: Rm. S-512, University of California San Francisco, 513 Parnassus Avenue, San Francisco, CA 94143-0424, USA. Tel.: +1-415-476-4866; fax: +1-415-476-6482

Received 27 November 2002 ,Accepted 11 December 2002.

References 

  1. MacDonald DG, Saka SM. Structural indicators of the high risk lesion. In:  Johnson NW editors. Risk markers for oral diseases. Cambridge: Cambridge University Press; 1991;p. 165–187
  2. Mincer HH, Coleman SA, Hopkins KP. Observations on the clinical characteristics of oral lesions showing histologic epithelial dysplasia. Oral Surg Oral Med Oral Pathol. 1972;33:389–399
  3. Lumerman H, Freedman P, Kerpel S. Oral epithelial dysplasia and the development of invasive squamous cell carcinoma. Oral Surg Oral Med Oral Pathol. 1995;79:321–329
  4. Sudbo J, Kildal W, Risberg B, Koppang HS, Danielsen HE, Reith A. DNA content as a prognostic marker in patients with oral leukoplakia. N Engl J Med. 2001;344(17):1270–1278
  5. Silverman SJ, Gorsky M, Lozada F. Oral leukoplakia and malignant transformation. A follow-up study of 257 patients. Cancer. 1984;53(3):563–568
  6. Shepman KP, van der Meij EH, Smeele LE, van der Waal I. Malignant transformation of oral leukoplakia (a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands). Oral Oncol, Eur J Cancer. 1998;34:270–275
  7. Duffy MJ. The role of proteolytic enzymes in cancer invasion and metastasis. Clin Exp Metastasis. 1992;10(3):145–155
  8. Duffy MJ. Proteases as prognostic markers in cancer. Clin Cancer Res. 1996;2(4):613–618
  9. Kos J, Lah TT. Cysteine proteinases and their endogenous inhibitors (target proteins for prognosis, diagnosis and therapy in cancer review). Oncol Rep. 1998;5(6):1349–1361
  10. Guinec N, Pagano M, Dalet-Fumeron V, Engler R. “In vitro” digestion of intact bovine lens capsules by four human lysosomal cysteine-proteinases. Biol Chem Hoppe Seyler. 1990;371(Suppl.):239–254
  11. Thomssen C, Schmitt M, Goretzki L, Oppelt P, Pache L, Dettmar P, et al.  Prognostic value of the cysteine proteases cathepsins B and cathepsin L in human breast cancer. Clin Cancer Res. 1995;1(7):741–746
  12. Adenis A, Huet G, Zerimech F, Hecquet B, Balduyck M, Peyrat JP. Cathepsin B, L, and D activities in colorectal carcinomas (relationship with clinico-pathological parameters). Cancer Lett. 1995;96(2):267–275
  13. Farinati F, Herszenyi L, Plebani M, Carraro P, De Paoli M, Cardin R. Increased levels of cathepsin B and L, urokinase-type plasminogen activator and its inhibitor type-1 as an early event in gastric carcinogenesis. Carcinogenesis. 1996;17(12):2581–2587
  14. Roger P, Montcourrier P, Maudelonde T, Brouillet JP, Pages A, Laffargue F, et al.  Cathepsin D immunostaining in paraffin-embedded breast cancer cells and macrophages: correlation with cytosolic assay. Hum Pathol. 1994;25(9):863–871
  15. Morikawa W, Yamamoto K, Ishikawa S, Takemoto S, Ono M, Fukushi J, et al.  Angiostatin generation by cathepsin D secreted by human prostate carcinoma cells. J Biol Chem. 2000;275(49):38912–38920
  16. Felbor U, Dreier L, Bryant RA, Ploegh HL, Olsen BR, Mothes W. Secreted cathepsin L generates endostatin from collagen XVIII. EMBO J. 2000;19(6):1187–1194
  17. Vigneswaran N, Zhao W, Dassanayake A, Muller S, Miller DM, Zacharias W. Variable expression of cathepsin B and D correlates with highly invasive and metastatic phenotype of oral cancer. Hum Pathol. 2000;31(8):931–937
  18. Strojan P, Budihna M, Smid L, Vrhovec I, Skrk J. Cathepsin D in tissue and serum of patients with squamous cell carcinoma of the head and neck. Cancer Lett. 1998;130(1-2):49–56
  19. Strojan P, Budihna M, Smid L, Svetic B, Vrhovec I, Skrk J. Cathepsin B and L and stefin A and B levels as serum tumor markers in squamous cell carcinoma of the head and neck. Neoplasma. 2001;48(1):66–71
  20. Alevizos I, Mahadevappa M, Zhang X, Ohyama H, Kohno Y, Posner M, et al.  Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis. Oncogene. 2001;20:6196–6204
  21. Shahnavaz SA, Bradley G, Regezi JA, Thakker N, Gao L, Hogg D, et al.  Patterns of CDKN2A gene loss in sequential oral epithelial dysplasias and carcinomas. Cancer Res. 2001;61:2371–2375
  22. Macabeo-Ong M, Ginzinger DG, Dekker NP, McMillan A, Regezi JA, Wong DTW, et al.  Effect of formalin fixation time on tissues for quantitative mRNA expression analysis. Modern Pathol. 2002;15(9):979–987
  23. Godfrey TE, Kim SH, Chavira M, Ruff DW, Warren RS, Gray JW, et al.  Quantitative mRNA expression analysis from formalin-fixed, paraffin- embedded tissues using 5′ nuclease quantitative reverse transcription-polymerase chain reaction. J Mol Diagn. 2000;2(2):84–91
  24. PE Applied Biosystems. ABI Prism 7700 detection system: relative quantitation of gene expression. User bulletin #2.36.2001. Norwalk (CT) 1997.
  25. Shahnavaz SA, Regezi JA, Bradley G, Dube ID, Jordan RCK. p53 gene mutations in sequential oral epithelial dysplasias and carcinomas. J Pathol. 2000;190:417–422
  26. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques (a comparison between ABC and unlabeled antibody (PAP) procedures). J Histochem Cytochem. 1981;29:577–5780
  27. Ginzinger DG, Godfrey TE, Nigro J, Moore DH, Suzuki S, Pallavicini MG, et al.  Measurement of DNA copy number at microsatellite loci using quantitative PCR analysis. Cancer Res. 2000;60(19):5405–5409
  28. Walker RA. The histochemistry of glycosidases in human benign and malignant breast tissue. J Pathol. 1984;143(1):39–50
  29. Strojan P, Budihna M, Smid L, Svetic B, Vrhovec I, Kos J, et al.  Prognostic significance of cysteine proteinases cathepsins B and L and their endogenous inhibitors stefins A and B in patients with squamous cell carcinoma of the head and neck. Clin Cancer Res. 2000;6(3):1052–1062
  30. Heylen N, Vincent LM, Devos V, Dubois V, Remacle C, Trouet A. Fibroblasts capture cathepsin D secreted by breast cancer cells (possible role in the regulation of the invasive process). Int J Oncol. 2002;20(4):761–767
  31. Ikeguchi M, Sakatani T, Ueta T, Fukuda K, Oka S, Hisamitsu K, et al.  Correlation between cathepsin D expression and p53 protein nuclear accumulation in oesophageal squamous cell carcinoma. J Clin Pathol. 2002;55(2):121–126
  32. Kashida H, Kawamata H, Ichikawa K, Morita K, Imura J, Fujimori T. Intracytoplasmic localization of cathepsin D reflects the invasive potential of gastric carcinoma. J Gastroenterol. 2001;36(12):809–815
  33. Bartenjev I, Rudolf Z, Stabuc B, Vrhovec I, Perkovic T, Kansky A. Cathepsin D expression in early cutaneous malignant melanoma. Int J Dermatol. 2000;39(8):599–602
  34. Goussia A, Ioachim E, Peschos D, Assimakopoulos D, Vougiouklakis T, Skevas A, et al.  Immunohistochemical expression of cathepsin D in laryngeal epithelial lesions: correlation with CD44 expression, p53 and Rb status and proliferation associated indices. Anticancer Res. 1999;19(4B):3055–3060
  35. Budihna M, Strojan P, Smid L, Skrk J, Vrhovec I, Zupevc A, et al.  Prognostic value of cathepsins B, H, L, D and their endogenous inhibitors stefins A and B in head and neck carcinoma. Biol Chem Hoppe Seyler. 1996;377(6):385–390
  36. Kawasaki G, Kato Y, Mizuno A. Cathepsin expression in oral squamous cell carcinoma (relationship with clinicopathologic factors). Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;93(4):446–454

PII: S1368-8375(03)00034-4

doi: 10.1016/S1368-8375(03)00034-4

Oral Oncology
Volume 39, Issue 7 , Pages 638-647 , October 2003

Article Tools

* Image Usage & Resolution